Vafa Shahabi
7Patents
6h-index
6Co-inventors
52Inventor score
Filing activity: May 10, 2007 → Nov 1, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9017660B2 | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors | Human Necessities | 21 | Active |
| US9549973B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 16 | Active |
| US9084747B2 | Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors | Human Necessities | 16 | Active |
| US9012141B2 | Compositions and methods comprising KLK3 of FOLH1 antigen | Chemistry; Metallurgy | 13 | Active |
| US9650639B2 | Dual delivery system for heterologous antigens | Human Necessities | 10 | Active |
| US9644212B2 | Dual delivery system for heterologous antigens | Human Necessities | 10 | Active |
| US11446369B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.